Transumbilical laparoendoscopic single-site surgery of simple nephrectomy of nonfunctioning kidney: a two-year experience

Background： Laparoendoscopic single-site surgery （LESS） may serve as a potential alternative to conventional laparoscopy and is developing quickly, but still in its infancy. The study is to present our two-year experience in transumbilical LESS simple nephrectomy （LESS-SN） for non-functioning kidney, in an effort to evaluate its feasibility, clinical outcomes and potential advantages. Methods： From December 2008 to December 2010, a total of 11 patients with body mass index （BMI）≤30 underwent transumbilical TriPortTM LESS-SN by a single experienced urologist at our institution. The indications for nephrectomy included nonfunctioning kidney associated with ureteropelvic junction stricture （n=l）, ureteral calculi （n=6）, tuberculosis （n=3）, and ureteral stricture （n=l）. Patient demographics perioperative and follow-up data were prospectively collected and analyzed. Results： Ten procedures were successfully completed with one patient converted to open surgery due to uncontrollable bleeding. The mean operative time was 189.2 （ranging 100-320 min） with an estimated blood loss of 204.5 （ranging 50-1 000 ml）. There were two complications of bleeding （1- intra-, 1- post-）. The mean hospitalization after surgery was 7.9 d （ranging 4-17 d） With a regular follow-up of 1, 6, 12, and 24 months after surgery, all patients remained symptom-free with an intra-umbilical scar. Conclusion： Transumbilical LESS simple nephrectomy for nonfunctioning kidney can be accomplished with favorable surgical outcomes and a superiority of cosmesis. However, cases with chronic inflammation are not suitable for initial up-take and should only be attempted by the very experienced laparoscopist.

Transumbilical laparoendoscopic single-site surgery(LESS) partial nephrectomy:a median follow-up of 2 years

Objective:Nephron-sparing surgery(NSS) for small renal masses offers a similar functional and oncological outcome to that of radical surgery.Laparoendoscopic single-site surgery(LESS) emerges as an advanced alternative for reduced invasiveness and improves cosmesis;LESS is developing quickly and its indications have been expanded,but still in its infancy.The aim of this paper is to report our preliminary experience in transumbilical LESS partial nephrectomy(LESS-PN),so as to assess its utility, safety and efficacy.Methods:From August 2009 to October 2010,3 patients underwent transumbilical LESS-PN via a novel multi-channel TriPort by a single experienced urologist in our institution.Patient demographics,perioperative and follow-up data were prospectively collected and analyzed.Results:All the three procedures were successfully completed.A 5-mm ancillary trocar was utilized in all 3 cases.The mean operative duration was 226.3(210-254 min) with an estimated blood loss of 56.7 ml (20-100 ml).Mean warm ischemia time was 35.7 min(19-48 min).One patient was transfused due to postoperative bleeding. The recovery was uneventful and mean length of postoperative stay was 13 days(12-14 days).At the latest follow-up,all patients remained symptom-free and had normal renal function without evidence of recurrence,and they were delighted for a hidden transumbilical scar.Conclusion:Transumbilical LESS-PN is a feasible and safe procedure albeit extremely technically challenging.Surgical outcomes at a median follow-up of 2 years are promising,while currently it should be reserved for highly selected patients with favorable tumor anatomy and performed by a very experienced laparoscopic surgeon.

Initial experience of laparoendoscopic single-site radical prostatectomy with a novel purpose-built robotic system

Objective This prospective single-arm clinical trial aimed to evaluated the feasibility and safety of the application of the SHURUI system(Beijing Surgerii Technology Co.,Ltd.,Beijing,China),a novel purpose-built robotic system,in single-port robotic radical prostatectomy.Methods Sixteen patients diagnosed with prostate cancer were prospectively enrolled in and underwent robotic radical prostatectomy from October 2021 to August 2022 by the SHURUI single-port robotic surgical system.The demographic and baseline data,surgical,oncological,and functional outcomes as well as follow-up data were recorded.Results The mean operative time was 226.3(standard deviation[SD]52.0)min,and the mean console time was 183.4(SD 48.3)min,with the mean estimated blood loss of 116.3(SD 90.0)mL.The mean length of postoperative hospital stay was 4.50(SD 0.97)days.Two patients had postoperative complications(Clavien-Dindo Grade II),and both patients improved after conservative treatment.All patients’postoperative prostate-specific antigen levels decreased to below 0.2 ng/mL 1 month after discharge.The mean prostate-specific antigen level further decreased to a mean of 0.0219(SD 0.0641)ng/mL 6 months after surgery.Thirty days postoperatively,12 out of 16 patients reported using no more than one urinary pad per day,and all patients reported satisfactory urinary control without the need for pads 6 months after surgery.Conclusion The SHURUI system is safe and feasible in performing radical prostatectomy via both transperitoneal and extraperitoneal approaches.Tumor control and urinary continence were satisfying for patients enrolled in.The next phase involves conducting a large-scale,multicenter randomized controlled trial to thoroughly assess the effectiveness and safety of the new technology in a broader population.

A Comparison between Laparoendoscopic Single-Site and Conventional Laparoscopic Renal Stone Removal Surgery: A Study of Application in Two Cases

Aim: To present our initial experience of applying laparoendoscopic single-site surgery (LESS) nephrolithotomy in the treatment of renal calculi. Methods: In August 2010 and April 2012, the LESS nephrolithotomy technique was applied to treat two patients with a renal calculus. One patient had a calculus measuring 5 × 3 cm, and the second patient's measured 3 × 3 cm. Both patients underwent general anesthesia. The operations were performed through a retroperitoneal approach with a single-port instrument inserted through the retroperitoneal incision. The standard laparoscopic retroperitoneal technique was performed, and the calculi were removed by incising the area of the thin renal cortex and the renal pelvis, respectively. The operating time, estimated blood loss, intraoperative complications, other complications, drainage time, and post-operative hospital stay were recorded. Results: Both procedures were completed successfully. No additional trocars were added. No conversion to standard laparoscopic or open surgery was needed. The operating times were 130 min and 120 min, and the estimated blood losses were 40 mL and 30 mL. There were no intraoperative complications. The wound drainage times were 3 d and 2 d, respectively and the post-operative hospital stays were 8 d and 7 d, respectively. There was no secondary bleeding or wound infection. Follow-up times were 2 years and 3 months, respectively. No incidence of hydronephrosis was recorded. Conclusions: LESS nephrolithotomy is safe and feasible for treating kidney calculi. It can be applied in patients with large renal calculi and regionally thin renal parenchyma.

Laparoendoscopic single-site distal pancreatectomy in pigs

AIM: To explore the technique for laparoendoscopic single-site distal pancreatectomy.

Laparoendoscopic Single-Site Combined Hysterectomy and Nephrectomy in Deep Infiltrating Endometriosis

Within the advance ports and instruments, laparoendoscopic single-site (LESS) surgery has been increasingly used among gynaecologic surgeons. In addition, advanced port systems have enabled to perform concomitant surgical procedures via transumbilical incision. However, combined surgical operations are rarely reported in the literature, particularly in gynaecology. This case report presents a 42-year-old woman who undergo concomitant LESS hysterectomy and nephrectomy due to deep infiltrating endometriosis (DIE) and end stage renal disease. The operation is performed in approximately 3 hours without any complications, and the patient is discharged on postoperative third day. This case demonstrates that complex concomitant operations even in a patient with DIE can be performed using a LESS surgical approach.

Transurethral assistant transumbilical laparoendoscopic single-site radical prostatectomy

The laparoendoscopic single-site （LESS） technique is the latest technical innovation in laparoscopic surgery to undergo exponential development in urology. This study undertaken to illustrate our initial experience LESS radical prostatectomy （RP） and analyze early outcomes. Nineteen patients diagnosed with prostate cancer underwent LESS-RP in our institute. The patients were divided into two groups： conventional LESS and transurethral assistant LESS. Preoperative, perioperative, postoperative, pathologic, and functional outcomes data were assessed. With the help of a transurethral assistant, the mean operation and anastomosis time were decreased markedly. No focal positive margins were encountered. No prostate-specific antigen recurrence was detected 1 month postoperatively. Complete continence recovery （no pad） was observed in 32% of the patients at 1 month after the operation. No intraoperative and postoperative complications were reported, LESS-RP is a feasible and effective surgical procedure for treatment of prostate cancer. Moreover, transurethral assistant LESS could reduce the difficulty of LESS-RP and shorten the operation time.

Single-site laparoscopic partial nephrectomy: Where are we going?

AIM:To review an evolution of laparoscopic surgery,there has been a growing interest in laparoendoscopic single-site surgery(LESS).METHODS:A comprehensive electronic literature search was conducted using PubM ed database to identify all publications relating to LESS-partial nephrectomy(PN).The research includes articles published from April 2008 to January 2014.We focused our attention only on articles in which were cited the single-site surgical technique(laparoscopic and robotic),tumour stage and grade,mean tumour size,intraoperative variables,blood loss and transfusion rate,length of postoperative stay and complication rates,Clavien classification,positive of surgical margins,pain assessment at discharge.RESULTS:A total of 9 studies were collected with 221patients included.The mean patients age was 62 years.The mean tumor size was 2.35 cm with a mean operative time of 181 min(range 111-270 min)and 58.3%were done by robot.The mean ischemia time was 23.6min.The 25.8%of patients underwent an unclamp LESS-PN.Mean estimated blood loss was 296 mL and median length of hospital stay was 4 d.The rate of severe post-operative complications(≥Clavien gradeⅢ)was 5.4%.Not all surgical series of LESS-PN or Robotic-LESS-PN shows conversion in Multiport Laparoscopic or Open Surgery.Regarding oncologic outcomes,surgical margins were positive 4%of patients(9/221),no distant or port-site metastases were recorded.CONCLUSION:LESS-PN and RLESS-PN are feasible and associated with reduced postoperative pain,shorter median hospital stay,shorter recovery time,and better cosmetic satisfaction without compromising surgical and oncological safety.

郑氏4C悬吊法经脐单孔腹腔镜手术治疗宫颈癌的疗效及预后分析

目的探讨郑氏4C悬吊法经脐单孔腹腔镜手术(TU-LSSS)治疗宫颈癌的疗效,并分析其预后。方法选取我院收治的宫颈癌患者92例,并随机分为对照组(传统腹腔镜术)和观察组(郑氏4C悬吊法TU-LSSS),每组46例。比较2组患者围术期相关指标。随访3年,记录患者无进展生存期(PFS)和总生存期(OS),并分析预后的影响因素。结果与对照组比较,观察组患者手术时间更长(P<0.05),术中出血量更少(P<0.05),术后肠鸣音恢复时间、住院时间更短(P<0.05),术后3年PFS率、3年OS率更高(P<0.05)。随访3年,疾病进展或死亡共11例。经单因素分析,预后良好组与预后不良组患者肿瘤直径、临床分期、淋巴结转移、脉管浸润、治疗方法比较,差异有统计学意义(P<0.05);二元Logistic回归分析显示,肿瘤直径(≥4 cm)、临床分期(≥ⅠB2期)、淋巴结转移、脉管浸润是宫颈癌预后的危险因素(P<0.05),郑氏4C悬吊法TU-LSSS是保护因素(P<0.05)。结论郑氏4C悬吊法TU-LSSS治疗宫颈癌可有效促进患者恢复,提高3年PFS率和OS率。预后与多种因素有关,需根据不同危险因素给予针对性处理。

三种腹腔镜手术在异位妊娠治疗的临床对比研究

目的比较经阴道自然腔道内镜手术(transvaginal natural orifice transluminal endoscopic surgery,v-NOTES)、经脐单孔腹腔镜手术(transumbilical laparoendoscopic single site surgery,TU-LESS)及传统腹腔镜手术治疗异位妊娠的疗效与差异。方法回顾性选取2019年6月至2022年6月扬州大学医学院附属扬州市妇幼保健院收治的异位妊娠患者121例,根据手术方式不同将纳入患者分为传统腹腔镜组(49例)、TU-LESS组(43例)和v-NOTES组(29例)。观察各组患者的年龄、体质量指数(body mass index,BMI)、血红蛋白(hemoglobin,Hb)、手术时间、术中出血、术后排气时间、术后24h视觉模拟评分法(visual analogue scale,VAS)评分、术后住院时间和满意度。结果v-NOTES组患者的排气时间、术后住院时间均显著短于传统腹腔镜组和TU-LESS组,术后24h VAS评分显著低于传统腹腔镜组和TU-LESS组(P<0.05);三组患者的术后满意度比较差异有统计学意义(H=57.364,P<0.001),且v-NOTES组>TU-LESS组>传统腹腔镜组。结论与TU-LESS和传统腹腔镜手术比较,v-NOTES治疗异位妊娠术后恢复快,疼痛轻,更加美观,但需要手术者熟练掌握。

改良经脐单孔腹腔镜子宫肌瘤剔除术的临床应用效果分析

目的评估改良经脐单孔腹腔镜子宫肌瘤剔除术的临床应用价值。方法回顾性分析行腹腔镜下子宫肌瘤剔除术患者75例,按手术方式不同分为改良经脐单孔腹腔镜组(38例,行改良经脐单孔腹腔镜子宫肌瘤剔除术,脐部自制Port及左下腹0.5 cm预置引流孔)、传统多孔腹腔镜组(37例,行传统多孔腹腔镜子宫肌瘤剔除术)。比较两组手术时间,术中出血量,术后引流管拔除时间,抗生素使用情况,术后住院时间,住院费用。结果改良经脐单孔腹腔镜组与传统多孔腹腔镜组的手术时间[(76.26±22.10)min VS(83.24±22.21)min,P=0.177]及术中出血量[(55.52±32.85)ml VS(63.51±27.71)ml,P=0.259]比较,差异无统计学意义(P>0.05);改良经脐单孔腹腔镜组与传统多孔腹腔镜组的术后引流管拔除时间[(48.42±19.16)h VS(64.72±21.87)h,P=0.001]及术后住院时间[(4.18±1.01)d VS(5.08±1.08)d,P=0.000]比较改良经脐单孔腹腔镜组更短,抗生素使用率[31.58%(12/38)VS 54.05%(20/37),P=0.049]及住院费用[(14.02±2.2)千元VS(15.73±2.8)千元,P=0.004]比较改良经脐单孔腹腔镜组更低(P<0.05)。结论改良经脐单孔腹腔镜子宫肌瘤剔除术兼顾无瘤化操作及更微创的手术效果,通过改良手术步骤,使其手术难度与传统多孔腹腔镜相比无明显增加,值得临床推广。

Single-incision laparoscopic surgery for biliary tract disease

Single-incision laparoscopic surgery(SILS), or laparoendoscopic single-site surgery, has been employed in various fields to minimize traumatic effects over the last two decades. Single-incision laparoscopic cholecystectomy(SILC) has been the most frequently studied SILS to date. Hundreds of studies on SILC have failed to present conclusive results. Most randomized controlled trials(RCTs) have been small in scale and have been conducted under ideal operative conditions. The role of SILC in complicated scenarios remains uncertain. As common bile duct exploration(CBDE) methods have been used for more than one hundred years, laparoscopic CBDE(LCBDE) has emerged as an effective, demanding, and infrequent technique employed during the laparoscopic era. Likewise, laparoscopic biliary-enteric anastomosis is difficult to carry out, with only a few studies have been published on the approach. The application of SILS to CBDE and biliary-enteric anastomosis is extremely rare, and such innovative procedures are only carried out by a number of specialized groups across the globe. Herein we present a thorough and detailed analysis of SILC in terms of operative techniques, training and learning curves, safety and efficacy levels, recovery trends, and costs by reviewing RCTs conducted over the past three years and two recently updated meta-analyses. All existing literature on single-incision LCBDE and singleincision laparoscopic hepaticojejunostomy has been reviewed to describe these two demanding techniques.

Single-incision laparoscopic surgery to treat hepatopancreatobiliary cancer:A technical review

Single-incision laparoscopic surgery(SILS),or laparoendoscopic single-site surgery,was launched to minimize incisional traumatic effects in the 1990s.Minor SILS,such as cholecystectomies,have been gaining in popularity over the past few decades.Its application in complicated hepatopancreatobiliary(HPB)surgeries,however,has made slow progress due to instrumental and technical limitations,costs,and safety concerns.While minimally invasive abdominal surgery is pushing the boundaries,advanced laparoscopic HPB surgeries have been shown to be comparable to open operations in terms of patient and oncologic safety,including hepatectomies,distal pancreatectomies(DP),and pancreaticoduodenectomies(PD).In contrast,advanced SILS for HPB malignancy has only been reported in a few small case series.Most of the procedures involved minor liver resections and DP;major hepatectomies were rarely described.Singleincision laparoscopic PD has not yet been reported.We herein review the published SILS for HPB cancer in the literature and our three-year experience focusing on the technical aspects.

Laparoendoscopic single-site radical prostatectomy： technique and initial outcomes

Background Laparoendoscopic single-site surgery radical prostatectomy （LESS-RP） is a challenging urological procedure and needs to be further evaluated. This study was undertaken to illustrate the safety and initial results of pure LESS-RP with conventional available instruments.

Preliminary experience with transperitoneal laparoendoscopic single-site radical nephrectomy using a home-made single-port device in China

Background Laparoendoscopic single-site （LESS） surgery represents a technique to further reduce morbidity and scarring associated with surgery.We present our preliminary experience with transperitoneal LESS radical nephrectomy （RN） using a home-made single-port device in China.Methods From July 2010 to November 2011,eleven patients with renal tumor not greater than T2 underwent LESS-RN by an experienced laparoscopic surgeon.A home-made single-port device was used through a 5-cm umbilical incision.A combination of standard and articulating laparoscopic instruments was used.The sequence of steps of LESS-RN was similar to transperitoneal laparoscopic RN.Patient characteristics,perioperative variables and postoperative outcomes were recorded and analyzed.Results Except for two transperitoneal laparoscopic conversions and one hand-assisted laparoscopic conversion,the other procedures were completed successfully without conversion to open surgery.The mean operative time was 224.5 （155-297） minutes,estimated blood loss was 270.9 （50-900） ml,and hospital stay was 10.4 （5-15） days.The mean visual analog pain scale （VAPS） on the first postoperative day was 4.0/10.Final pathological analysis revealed renal cell carcinoma in all cases with a stage distribution of three T1a,five T1b,and three T2a tumors.With the mean followup period of 21.4 （12-28） months,all patients were alive without evidence of tumor recurrence or metastasis,and were satisfied with the appearance of the scars.Conclusion Transperitoneal LESS-RN using a home-made single-port device is technically feasible and safe in a selected group of patients （low body mass index and stage tumor） and has excellent cosmetic results.Although preliminary oncologic outcome is not compromised,the long-term evaluation of these patients is awaited.

Laparoscopic single site surgery: Experience in pediatric urology

Laparoendoscopic single-site surgery(LESS) has been developed to benefit patients by enabling surgeons to perform scarless surgery. In this review we aimed to summarize and critically analyze the available evidence on the current status and future prospects for LESS in pediatric urology, with special emphasis on our experience with LESS in children. The clinical data available clearly demonstrate that LESS can safely and effectively be performed in a variety of pediatric urology settings. As clinical experience increases, expanding indications are expected to be documented and the efficacy of the procedure to improve. So far, the quality of evidence of all available studies remains low; mostly being small case series or case-control studies from selected centers. Thus, the only objective benefit of LESS remains improved cosmetic outcome. Prospective randomized studies are awaited to determine which LESS procedures will be established and which are unlikely to stand the test of time. Technological advances hold promise to minimize the challenging technical nature of scarless surgery. In this respect, robotics may be a driving force in the development of LESS.

基于倾向性评分匹配的经脐单孔腹腔镜与传统腹腔镜手术治疗卵巢囊肿的疗效分析

目的探讨经脐单孔腹腔镜手术治疗卵巢囊肿的疗效和安全性。方法回顾性分析2020年1月~2021年12月我院252例腹腔镜卵巢囊肿剥除术的临床资料,其中单孔腹腔镜卵巢囊肿剥除术58例(单孔组),传统腹腔镜卵巢囊肿剥除术194例(四孔组),经倾向性评分匹配(propensity score matching,PSM),最终49对数据成功匹配,比较2组手术时间、术中出血量、术后胃肠道恢复排气时间、住院时间、术中囊肿溢出率、术后围术期疼痛评分、术后瘢痕满意度、术后并发症发生率、住院总费用及囊肿复发率等。结果单孔组和四孔组比较,住院总费用较高[15125.3(13851.2,16420.0)元vs.13439.3(11993.1,15804.9)元,Z=-2.995,P=0.003],术后胃肠道恢复排气时间缩短[15.8(14.0,18.0)h vs.19.0(16.6,22.2)h,Z=-4.973,P=0.000],住院时间缩短[5(5,6)d vs.7(6,7)d,Z=-4.376,P=0.000],术后24 h疼痛评分较低[4(4,5)分vs.5(4,6)分,Z=-4.225,P=0.000],术后切口瘢痕满意度较高(97.9%vs.87.3%,χ^(2)=4.404,P=0.036)。2组手术时间[80(60,90)min vs.70(50,90)min,Z=-1.005,P=0.315]、术中出血量[20(10,50)ml vs.20(10,50)ml,Z=-0.154,P=0.878]、术中囊肿溢出率[20.4%(10/49)vs.20.4%(10/49),χ^(2)=0.000,P=1.000]、术后并发症发生率[4.1%(2/49)vs.8.2%(4/49),χ^(2)=0.178,P=0.673]均无统计学差异。2组患者短期随访均无囊肿复发。结论单孔腹腔镜卵巢囊肿剥除术是一种安全、有效的术式,术后短期疼痛及切口满意度较传统腹腔镜手术具有显著优势。

经脐单孔腹腔镜治疗卵巢子宫内膜异位囊肿剔除术的临床应用

目的探讨经脐单孔腹腔镜手术在治疗卵巢子宫内膜异位囊肿患者的安全性和临床效果。方法选取2018年10月至2021年12月在南通大学第二附属医院治疗的卵巢子宫内膜异位囊肿患者102例,其中经脐单孔腹腔镜手术治疗组(单孔组,50例)和传统多孔腹腔镜手术治疗组(多孔组,52例);比较两组患者的手术时间、术中出血量、术后排气时间、住院时间、术后并发症、发热情况、术后24 h疼痛视觉模拟评分(visual analogue scale,VAS)、体象量表(body image scale,BIS)及美容评分(cosmetic score,CS)。结果经脐单孔腹腔镜手术组和传统多孔腹腔镜手术组术中出血量、住院时间、并发症发生情况(均为0例)及术后发热情况(均为0例)比较,差异均无统计学意义(P>0.05)。单孔组手术时间较多孔组长,术后排气时间较多孔组快,术后24 h VAS较多孔组低,术后切口美观满意度评分BIS及CS均高于多孔组,差异均有统计学意义(P<0.05)。结论经脐单孔腹腔镜手术治疗卵巢子宫内膜异位囊肿是安全可行的,具有明显减轻术后疼痛,加快术后肠道恢复,切口美观的优点。

经脐单孔腹腔镜下卵巢囊肿剥除术治疗卵巢囊肿对术后疼痛及卵巢储备功能的影响

目的:研究经脐单孔腹腔镜(TU-LESS)下卵巢囊肿剥除术治疗卵巢囊肿对术后疼痛及卵巢储备功能的影响。方法:以2019年1月-2022年1月樟树市人民医院收治的80例卵巢囊肿患者为对象进行研究,根据系统化随机法将其分为单孔组(n=40)和三孔组(n=40)。单孔组予TU-LESS卵巢囊肿剥除术,三孔组予传统三孔腹腔镜卵巢囊肿剥除术。比较两组围手术期指标(术中出血量、术后排气时间、住院时间、术中卵巢囊肿破裂率)。使用视觉模拟评分法(VAS)评分比较两组术后1、3 d疼痛程度。记录围手术期并发症。比较术后1、3个月两组血清激素[促黄体生成素(LH)、雌二醇(E2)]变化。术后随访6个月,统计两组卵巢囊肿的复发情况。结果:单孔组术中出血量少于三孔组,术后排气时间、住院时间均短于三孔组,术后1、3 d VAS评分均低于三孔组(P<0.05)。术后3个月,两组E2水平较术后1个月均升高(P<0.05),且单孔组高于三孔组(P<0.05);两组LH水平较术后1个月均降低(P<0.05),且单孔组低于三孔组(P<0.05)。两组卵巢囊肿破裂率、围手术期并发症发生情况及卵巢囊肿复发情况比较,差异均无统计学意义(P>0.05)。结论:相较于三孔腹腔镜手术,TU-LESS卵巢囊肿剥除术治疗卵巢囊肿具有术中创伤小、恢复快等优点,对减少患者术后疼痛感及控制手术对卵巢储备功能损伤有利。

经脐单孔腹腔镜大子宫切除术的临床效果

目的探讨经脐单孔腹腔镜大子宫切除术的临床可行性、安全性及优势。方法选取行腹腔镜大子宫切除术的患者82例为研究对象。其中,行经脐单孔腹腔镜手术患者41例为单孔组,行传统多孔腹腔镜手术患者41例为多孔组。比较2组患者的手术时间、术中出血量、术后24 h视觉模拟评分(VAS)、术后排气时间、术后病率、术后住院时间、切口美容评分、术后第1天炎症指标、中性粒细胞与淋巴细胞比值(NLR)、并发症发生情况及术前和术后的血红蛋白差值。结果2组患者手术均顺利完成,无中转开腹,且未发生严重手术并发症,单孔组未添加辅助孔。单孔组术后排气时间短于多孔组,术后24 h VAS评分、术后第1天NLR低于多孔组,术后切口美容度评分高于多孔组,差异有统计学意义(P<0.05)。结论在严格把握手术适应证的情况下,经脐单孔腹腔镜大子宫切除术安全性较好,可行性较高,其具有术后排气快、术后疼痛轻、免疫抑制轻以及切口美观等优势。